新生児スクリーニング市場：製品タイプ、技術、エンドユーザー別-2025～2030年の世界予測

新生児スクリーニング市場は、2023年に9億7,689万米ドルと評価され、2024年には10億6,441万米ドルに達すると予測され、CAGR 8.83%で成長し、2030年には17億6,745万米ドルに達すると予測されています。

新生児スクリーニングは、治療可能なさまざまな遺伝、内分泌、代謝疾患について出生直後の乳児を検査する重要な公衆衛生の取り組みです。このような疾患の有病率の上昇に伴い、新生児スクリーニングの世界市場は、診断法の進歩や政府支援の増加に牽引され、持続的な成長を遂げています。さまざまなアプリケーションをカバーするこれらのスクリーニングは、合併症を予防することで医療費を大幅に削減できる早期発見を提供し、健康状態の改善を促します。新生児スクリーニング検査の主なエンドユーザーは、病院、診断センター、専門クリニックです。市場成長の重要な影響要因は、より包括的で非侵襲的かつ正確な検査手法をもたらした技術革新です。さらに、病気の早期発見の重要性に対する保護者の意識の高まりや、有利なヘルスケア政策が需要を押し上げています。電子カルテ（EHR）や遠隔医療など、ヘルスケアにおける高度なITソリューションの統合は、シームレスなデータ管理と相互接続を容易にすることで、市場の見通しをさらに高めています。主な潜在機会は、特に検診インフラがまだ発展途上にある新興国市場において、より多くの疾患を含む検査パネルの拡大にあります。しかし、高度な検査技術のコスト高、特定地域での資金不足、規制の複雑さ、熟練した専門家の不足といった課題が、市場の成長を阻害する可能性があります。また、倫理的な懸念や、国によってスクリーニングのガイドラインにばらつきがあり、標準化に影響を及ぼす可能性があることも、限界の原因となっています。革新は、費用対効果の高い迅速結果技術の開発と、スクリーニングの適用範囲を改善するための強固な官民パートナーシップの構築に集中することができます。個別化された新生児ヘルスケアソリューションに焦点を当て、新生児スクリーニングの重要性に関する教育活動を拡大することで、企業はこれらの成長手段を活用することができます。全体として、新生児スクリーニング市場は、公衆衛生の進歩を促進するイノベーションの態勢が整ったダイナミックなセクターであり続けています。

市場力学：急速に進化する新生児スクリーニング市場の主要市場インサイトを公開

新生児スクリーニング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 乳幼児人口の増加と乳幼児早期健康評価の必要性
  • 世界の新生児スクリーニングプログラムの増加
  • 新生児スクリーニングに対する払い戻しの利用可能性
• 市場抑制要因
  • 乳幼児の熟練したケアとスクリーニングの欠如
• 市場機会
  • 新生児スクリーニング活動の認可増加
  • 新生児スクリーニングの技術的進歩
• 市場の課題
  • 新生児スクリーニング処置の不正確さ問題

ポーターのファイブフォース：新生児スクリーニング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、新生児スクリーニング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：新生児スクリーニング市場における外部からの影響の把握

外部マクロ環境要因は、新生児スクリーニング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析新生児スクリーニング市場における競合情勢の把握

新生児スクリーニング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス新生児スクリーニング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、新生児スクリーニング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨新生児スクリーニング市場における成功への道筋を描く

新生児スクリーニング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 乳幼児人口の増加と早期乳幼児健康診断の必要性
    • 世界中で新生児スクリーニングプログラムが増加
    • 新生児スクリーニングの払い戻しの可否
  • 抑制要因
    • 乳児の熟練したケアとスクリーニングの欠如
  • 機会
    • 新生児スクリーニング活動の承認率の向上
    • 新生児スクリーニングにおける技術の進歩
  • 課題
    • 新生児スクリーニング手順の不正確さの問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 新生児スクリーニング市場：製品別

• 消耗品
• 機器

第7章 新生児スクリーニング市場テストタイプ別

• ＣＣＨＤ
• 乾燥した血痕
• 聴覚スクリーニング

第8章 新生児スクリーニング市場：技術別

• 酵素アッセイ
• 免疫測定
• 分子
• パルスオキシメトリー
• タンデム質量分析法

第9章 新生児スクリーニング市場：エンドユーザー別

• 臨床検査室
• 病院

第10章 南北アメリカの新生児スクリーニング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の新生児スクリーニング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの新生児スクリーニング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Baebies, Inc.
• Bio-Rad Laboratories
• Covidien PLC
• Danaher Corporation
• Demant A/S
• GE Healthcare
• Medtronic Plc
• MP BIOMEDICALS
• Natus Medical Incorporated
• PerkinElmer, Inc.
• Thermo Fisher Scientific Inc.
• Trivitron Healthcare

LIST OF FIGURES

• FIGURE 1. NEWBORN SCREENING MARKET RESEARCH PROCESS
• FIGURE 2. NEWBORN SCREENING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. NEWBORN SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. NEWBORN SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEWBORN SCREENING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEWBORN SCREENING MARKET DYNAMICS
• TABLE 7. GLOBAL NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEWBORN SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEWBORN SCREENING MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEWBORN SCREENING MARKET SIZE, BY CCHD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEWBORN SCREENING MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HEARING SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEWBORN SCREENING MARKET SIZE, BY ENZYME ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEWBORN SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEWBORN SCREENING MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NEWBORN SCREENING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. CANADA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. CHINA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. INDIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. INDIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ITALY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. ITALY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. POLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. POLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. QATAR NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. QATAR NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. NEWBORN SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. NEWBORN SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

The Newborn Screening Market was valued at USD 976.89 million in 2023, expected to reach USD 1,064.41 million in 2024, and is projected to grow at a CAGR of 8.83%, to USD 1,767.45 million by 2030.

Newborn screening represents a critical public health initiative that involves testing infants shortly after birth for a variety of treatable genetic, endocrine, and metabolic disorders. With the rising prevalence of such conditions, the global newborn screening market is experiencing sustained growth, driven by advancements in diagnostics and increased governmental support. Covering an array of applications, these screenings provide early detection that can substantially reduce medical costs by preventing complications, fostering improved health outcomes. The primary end-users of newborn screening tests are hospitals, diagnostic centers, and specialized clinics. A crucial influencing factor in market growth is technological innovation, which has resulted in more comprehensive, non-invasive, and accurate testing methodologies. Additionally, growing awareness among parents about the importance of early disease detection and favorable healthcare policies are boosting demand. The integration of advanced IT solutions in healthcare, such as electronic health records (EHRs) and telemedicine, further enhances market prospects by facilitating seamless data management and interconnectivity. Key potential opportunities lie in the expansion of testing panels to include more conditions, especially in emerging markets where screening infrastructure is still developing. However, challenges such as the high costs of advanced testing technologies, insufficient funding in certain regions, regulatory complexities, and a shortage of skilled professionals can impede market growth. Limitations also stem from ethical concerns and variability in screening guidelines across countries, which may affect standardization. Innovations could be focused on developing cost-effective, rapid-result technologies and creating robust public-private partnerships to improve screening coverage. By focusing on personalized neonatal healthcare solutions and expanding educational efforts regarding the importance of newborn screening, businesses can leverage these avenues for growth. Overall, the newborn screening market remains a dynamic sector poised for innovations that foster public health advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Newborn Screening Market

The Newborn Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising infant population and need for early infant health assessment
  • Increasing newborn screening programs worldwide
  • Availability of reimbursements for newborn screening
• Market Restraints
  • Lack of skilled care and screening of the babies
• Market Opportunities
  • Rising authorization of newborn screening activities
  • Technological advancements in the newborn screening
• Market Challenges
  • Inaccuracy issues of newborn screening procedures

Porter's Five Forces: A Strategic Tool for Navigating the Newborn Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Newborn Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Newborn Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Newborn Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Newborn Screening Market

A detailed market share analysis in the Newborn Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Newborn Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Newborn Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Newborn Screening Market

A strategic analysis of the Newborn Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Newborn Screening Market, highlighting leading vendors and their innovative profiles. These include Baebies, Inc., Bio-Rad Laboratories, Covidien PLC, Danaher Corporation, Demant A/S, GE Healthcare, Medtronic Plc, MP BIOMEDICALS, Natus Medical Incorporated, PerkinElmer, Inc., Thermo Fisher Scientific Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Newborn Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instrument.
• Based on Test Type, market is studied across CCHD, Dried Blood Spot, and Hearing Screening.
• Based on Technology, market is studied across Enzyme Assay, Immunoassay, Molecular, Pulse Oximetry, and Tandem Mass Spectrometry.
• Based on End User, market is studied across Clinical Laboratories and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising infant population and need for early infant health assessment
    • 5.1.1.2. Increasing newborn screening programs worldwide
    • 5.1.1.3. Availability of reimbursements for newborn screening
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled care and screening of the babies
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising authorization of newborn screening activities
    • 5.1.3.2. Technological advancements in the newborn screening
  • 5.1.4. Challenges
    • 5.1.4.1. Inaccuracy issues of newborn screening procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Newborn Screening Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instrument

7. Newborn Screening Market, by Test Type

• 7.1. Introduction
• 7.2. CCHD
• 7.3. Dried Blood Spot
• 7.4. Hearing Screening

8. Newborn Screening Market, by Technology

• 8.1. Introduction
• 8.2. Enzyme Assay
• 8.3. Immunoassay
• 8.4. Molecular
• 8.5. Pulse Oximetry
• 8.6. Tandem Mass Spectrometry

9. Newborn Screening Market, by End User

• 9.1. Introduction
• 9.2. Clinical Laboratories
• 9.3. Hospitals

10. Americas Newborn Screening Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Newborn Screening Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Newborn Screening Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Baebies, Inc.
• 2. Bio-Rad Laboratories
• 3. Covidien PLC
• 4. Danaher Corporation
• 5. Demant A/S
• 6. GE Healthcare
• 7. Medtronic Plc
• 8. MP BIOMEDICALS
• 9. Natus Medical Incorporated
• 10. PerkinElmer, Inc.
• 11. Thermo Fisher Scientific Inc.
• 12. Trivitron Healthcare